Last price paid | 2.44 | |
Change | -2.79% [ -0.07 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | 31.05.2024 17:20 |
Fixing | n.a. |
Settlement date | 24.11.2022 |
Last trading | n.a. |
Final fixing | n.a. |
Currency redemption | CHF |
Perf. since issue | +61.67% |
Year to date (YTD) | +0.41% |
1 month | -8.61% |
3 months | -8.27% |
1 year | +46.11% |
3 years | n.a. |
Issue price | 1.50 |
Underlying price on issue | 306.10 |
Premium | 0.00% |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH1206985827 |
Symbol | IROIOZ |
Security | 120698582 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | n.a. |
Underlying | Roche Hldg G, CH0012032048 |
Underlying ISIN | CH0012032048 |
Funding level | 353.253200 |
Stop-loss level | 342.655600 |
Distance to stop-loss level | 47.51% |
Long/Short type | Short |
Subscription ratio | 50.00 |
Issuer | Zürcher Kantonalbank |
Exercise type | n.a. |
Minimum execution | n.a. |
Value day | 22.11.2022 |
Premium | 0.11% |
Premium p.a. | n.a. |
Leverage | 1.92 |
Moneyness | in-the-money |
Leverage | n.a. |
Delta | n.a. |
Intrinsic value | 120.953200 |
Break-even | n.a. |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Mini future (2210) |
Name | Price |
---|---|
Givaudan | 4'173.00 |
LOGITECH INT. | 88.64 |
Partners Group Ho... | 1'199.50 |
NOVARTIS N | 92.93 |
Swiss Re | 114.45 |